Cymbalta sales catalyst for Lilly's overall sales

Share this article:
Lilly credited increased Cymbalta sales for a 7% gain in overall sales for the 3rd Quarter, and said marketing and administrative costs were up 12%, due to increased advertising and promotion for the brand.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Pharmaceutical

This compelling e-book shares a wealth of insights designed to help members of sales forces connect with elusive HCPs. An expanded version has also been created that includes video interviews and other multimedia content. Click here for access.